PROTAC RIPK degrader-2
Based on 1 publication(s) in Google Scholar
PROTAC RIPK degraders -2 is a non-peptide PROTAC based on von Hippel-Lindau and targets serine-threonine kinase RIPK2, which is highly selective to the degradation of RIPK2. PROTAC RIPK degrader-2 acts as an activator to increase cell death and activate ion channels in cancer cells. PROTAC RIPK degrader-2 also can inhibit protein interactions, such as receptors and ligands, involved in a variety of diseases, such as cancer and diabetes.
(Pink: RIP kinase ligand (HY-43784); Blue: VHL ligand (HY-125845); Black: linker).
For research use only. We do not sell to patients.
- Purity: 99.89%
- CAS No.: 1801547-16-9
- Formula: C52H65N7O11S3
- Molecular Weight:1060.31
-
Storage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
-
Solvent & Solubility
- Purity & Documentation
- References
-
Help & FAQs
-
Apoptosis Compound Library
HY-L003
-
Kinase Inhibitor Library
HY-L009
-
NF-κB Signaling Compound Library
HY-L014
-
Anti-diabetic Compound Library
HY-L040
-
Heterocyclic Compound Library
HY-L138
-
PROTAC Library
HY-L151
-
Highly Selective Inhibitors Library
HY-L158
-
Serine/Threonine Kinase Inhibitor Library
HY-L164
-
Multi-Target Compound Library
HY-L176
-
Bioactive Compound Library Max
HY-L181
-
Bioactive Compound Library
HY-L001
-
Protein Kinase Compound Library
HY-L196
-
High-Throughput Bioactive Compound Library
HY-L205
-
Posttranslational Modification Library
HY-L226
Publications Citing Use of MedChemExpress (MCE) PROTAC RIPK degrader-2
MoreAll PROTACs Isoforms
More
Biological Activity
|
RIPK2 |
VHL |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| THP-1 | DC50 |
1.4 nM
Compound: 2
|
Protac activity against VHL/RIPK2 in human THP-1 cells assessed as induction of RIPK2 protein degradation
Protac activity against VHL/RIPK2 in human THP-1 cells assessed as induction of RIPK2 protein degradation
|
[PMID: 31035238] |
| THP-1 | IC50 |
656 nM
Compound: 2
|
Binding affinity to VHL in human THP-1 cells
Binding affinity to VHL in human THP-1 cells
|
[PMID: 31035238] |
PROTAC RIPK degrader-2 (0-30 μM, 16 h) dose-dependently downregulates RIPK protein levels in THP-1 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:THP-1 cells
-
Concentration:0-30 μM
-
Incubation Time:16 h
-
Result:Reduced ERRα levels by 50% and RIPK protein levels by ~20% in THP-1 cells.
Chemical Information
-
CAS No. 1801547-16-9
-
Appearance Solid
-
Molecular Weight 1060.31
-
Formula C52H65N7O11S3
-
Color Light yellow to yellow
-
SMILES
CC1=C(SC=N1)C2=CC=C(CNC([C@H]3N(C([C@H](C(C)(C)C)NC(COCCOCCOCCOCCOC4=CC5=C(C(NC6=CC=C(SC=N7)C7=C6)=CC=N5)C=C4S(C(C)(C)C)(=O)=O)=O)=O)C[C@H](O)C3)=O)C=C2
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years 4°C 2 years In solvent -80°C 2 years -20°C 1 year
Publications (1)
-
Journal Impact Factor
-
Most Recent
-
Sci Rep
Unraveling chain specific ubiquitination in cells using tandem ubiquitin binding entities. [Abstract]2025 Jul 2;15(1):22961. PMID: 40595035
Solvent & Solubility
DMSO : 150 mg/mL (141.47 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 7.5 mg/mL (7.07 mM); Clear solution
This protocol yields a clear solution of ≥ 7.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (75.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: 7.5 mg/mL (7.07 mM); Suspended solution; Need ultrasonic
This protocol yields a suspended solution of 7.5 mg/mL. Suspended solution can be used for oral and intraperitoneal injection.
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (75.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL.
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Purity & Documentation
-
Data Sheet (271 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Handling Instructions (2659 KB)
References
[1]. Bondeson DP, et al. Catalytic in vivo protein knockdown by small-molecule PROTACs. Nat Chem Biol. 2015 Aug;11(8):611-7. [Content Brief]
[2]. Wang C, et al. VHL-based PROTACs as potential therapeutic agents: Recent progress and perspectives. Eur J Med Chem. 2022 Jan 5;227:113906. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 0.9431 mL | 4.7156 mL | 9.4312 mL | 23.5780 mL |
| 5 mM | 0.1886 mL | 0.9431 mL | 1.8862 mL | 4.7156 mL | |
| 10 mM | 0.0943 mL | 0.4716 mL | 0.9431 mL | 2.3578 mL | |
| 15 mM | 0.0629 mL | 0.3144 mL | 0.6287 mL | 1.5719 mL | |
| 20 mM | 0.0472 mL | 0.2358 mL | 0.4716 mL | 1.1789 mL | |
| 25 mM | 0.0377 mL | 0.1886 mL | 0.3772 mL | 0.9431 mL | |
| 30 mM | 0.0314 mL | 0.1572 mL | 0.3144 mL | 0.7859 mL | |
| 40 mM | 0.0236 mL | 0.1179 mL | 0.2358 mL | 0.5895 mL | |
| 50 mM | 0.0189 mL | 0.0943 mL | 0.1886 mL | 0.4716 mL | |
| 60 mM | 0.0157 mL | 0.0786 mL | 0.1572 mL | 0.3930 mL | |
| 80 mM | 0.0118 mL | 0.0589 mL | 0.1179 mL | 0.2947 mL | |
| 100 mM | 0.0094 mL | 0.0472 mL | 0.0943 mL | 0.2358 mL |
PROTAC RIPK degrader-2 Related Classifications
HY-111866 Related Classifications
Powered by Bioz